These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 11527113

  • 1. Medical interventions in acute myocardial infarction.
    Sleight P.
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S113-9. PubMed ID: 11527113
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interventions during and after acute myocardial infarction.
    Sleight P.
    Postgrad Med J; 1983; 59 Suppl 3():80-8. PubMed ID: 6139802
    [Abstract] [Full Text] [Related]

  • 4. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH.
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [Abstract] [Full Text] [Related]

  • 5. [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period].
    Ambrosioni E, Bacchelli S, Borghi C.
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():132S-138S. PubMed ID: 9004813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Jagodzinski E, Senges J, Maximal Individual Therapy in Acute Myocardial Infarction Study Group.
    Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Secondary prevention after myocardial infarction].
    Czuriga I.
    Orv Hetil; 2002 Sep 15; 143(37):2117-28. PubMed ID: 12434627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 17. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V, Bergovec M.
    Acta Med Croatica; 2004 Jul 15; 58(2):123-7. PubMed ID: 15208797
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Repeat thrombolysis for acute myocardial infarction.
    Banerjee P, Clark AL, Norell MS.
    Int J Cardiol; 2005 Jul 20; 102(3):515-9. PubMed ID: 16004899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.